Core Viewpoint - VIKPRO showcased its new product, the "Nurturing Ovarian Pill," at the Vitafoods Europe 2025 event, highlighting its commitment to women's health and innovative nutritional solutions [1][7]. Group 1: Product Launch and Market Position - VIKPRO received dual first-place market position certifications for Coenzyme Q10 and Quercetin from Euromonitor International, affirming its status as a leader in sales and product quality [3]. - The "Nurturing Ovarian Pill" is designed to enhance ovarian vitality through a three-dimensional targeting strategy, addressing cellular repair, energy revitalization, and hormonal balance for women over 35 [7][9]. Group 2: Scientific Collaboration and Innovation - VIKPRO has established a strategic partnership with Düsseldorf Medical University and appointed Prof. Dr. Nicole Teusch as the chief scientific advisor to enhance its research capabilities and product development [5]. - The company emphasizes a cell-level health approach, integrating advanced German technology to innovate and upgrade its product offerings [5][12]. Group 3: Consumer Engagement and Market Strategy - The new product has been well-received in the Chinese market during the Tmall 618 pre-sale, indicating strong consumer interest and positive feedback [10]. - VIKPRO aims to continue expanding in the European health market, focusing on consumer needs and collaborating with global partners to deliver high-quality health products [12].